MOTS-c
A mitochondrially derived peptide studied in laboratory and animal research; not FDA-approved.
What it is
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA — part of a newly appreciated class of mitochondrial-derived peptides involved in metabolic signaling. As science, it is genuinely exciting; as a product, it is premature.
The evidence is cell and animal work on exercise capacity and insulin sensitivity, plus the first small human safety studies. No approved product exists, and anything sold as MOTS-c today is a research chemical without verified contents.
What researchers have actually studied it for
Metabolic regulation, insulin sensitivity and exercise physiology — in cell and animal studies, with human research only beginning.
How it works
Encoded inside the mitochondrial genome's 12S rRNA region — part of why its 2015 discovery was startling — MOTS-c translocates to the cell nucleus under metabolic stress and activates AMPK-linked programs, acting like an exercise-mimetic signal between mitochondria and the genome.
The molecule itself
A 16-amino-acid peptide encoded inside the mitochondrial genome's 12S rRNA gene — a 'mitochondrial-derived peptide,' a class whose existence rewrote assumptions about the tiny mitochondrial genome. Under metabolic stress it translocates to the nucleus, an unusual organelle-to-genome signaling route.
Where it came from
Identified in 2015 by researchers at USC exploring 'mitochondrial-derived peptides,' a class that rewrote assumptions about what the tiny mitochondrial genome encodes. Rodent papers on exercise capacity and insulin sensitivity made it famous; first-in-human dosing studies only began years later, and the science is still young.
The timeline
2015
Identified at USC; founding paper maps insulin-sensitivity effects in mice.
2016–19
Rodent exercise-capacity and obesity-resistance studies build the 'exercise peptide' narrative.
2019+
Human observational work links MOTS-c levels to metabolic states; analog safety studies begin.
2020s
Gray-market adoption far ahead of any human outcome data.
What the research record actually contains
- Rodent studies: improved insulin sensitivity, exercise capacity and diet-induced-obesity resistance.
- Human observational work linking MOTS-c levels to metabolic states.
- Early-phase human safety studies of analogs; no outcome trials.
What could change this assessment
Genuinely worth watching: mitochondrial-derived peptides are a live academic field, and MOTS-c analogs have entered early human study. If a metabolic-disease program matures, this becomes one of the rare gray-market names with a legitimate second act.
What's known about risks
Too early to characterize — the honest and complete statement. Early human safety work exists for related analogs; the gray-market vial has none of it behind it.
Where it stands legally
No approval anywhere; research-chemical channel only.
Worth asking a licensed provider
- 1.If metabolic health is the goal, what does my current exercise, diet and lab picture say first?
- 2.What proven interventions produce the effects MOTS-c shows in mice?
- 3.Is there legitimate trial participation in mitochondrial-peptide research?
Common claims, corrected
“It's exercise in a vial.”
Reality: It improved endurance measures in mice; no human performance study exists. The nickname is a rodent finding wearing gym clothes.
“Being 'from your mitochondria' makes it safe.”
Reality: Origin stories aren't safety data — synthetic administration of an endogenous signal at pharmacological levels is exactly what trials exist to characterize, and haven't.
MOTS-c FAQ
What does MOTS-c do?
In animal models it influences insulin sensitivity and exercise capacity, acting like an exercise-related metabolic signal. Human evidence is at the earliest stages — safety studies, not outcome trials.
Is MOTS-c 'the exercise peptide'?
That nickname comes from rodent studies where it improved performance measures. Extrapolating rodent endurance data to human athletic claims is exactly the leap the evidence doesn't support yet.
Is MOTS-c available as a drug?
No — no approval anywhere and no completed clinical program. Online vials are unregulated research chemicals.
What are mitochondrial-derived peptides?
Small peptides encoded within mitochondrial DNA — MOTS-c, humanin and others — discovered recently enough that their biology is still being mapped. A real frontier, which is different from a ready product.
Does exercise itself raise MOTS-c?
Human studies show exercise-responsive MOTS-c dynamics — pleasing symmetry: the evidence-backed way to engage this pathway is the training the compound's nickname imitates.